KCNQ2 and epilepsy: KCNQ2 loss-of-function (LoF) variants are associated with self-limiting neonatal epilepsy, while variants resulting in dominant-negative effects cause severe neonatal-onset developmental and epileptic encephalopathy [19, 24, 25].